Hikma Ventures
Corporate VCSeed–Late Stage · 12 people tracked
Investment thesis
Hikma Ventures seeks disruptive digital health and life sciences companies where strategic synergies exist with Hikma Pharmaceuticals' expertise. Key focus areas include drug delivery, digital therapeutics, clinical trial innovation, and treatments for respiratory, CNS, and oncology conditions, as well as chronic diseases like type II diabetes and hypertension. The fund partners actively with portfolio companies to leverage Hikma's global pharmaceutical reach and capabilities to accelerate growth. While stage-agnostic, the firm prefers Series A and later rounds, leads or co-leads investments, and deploys up to $5 million per company per round with a long-term investment horizon.
Source: firm website, verified Jul 21, 2026.
Team · 12 people
from the firm's websiteManaging Director at Hikma Ventures, quoted discussing the fund's establishment in 2015 and investment approach centered on digital health and life sciences.
What they invest in
from 2 of 19 portfolio companiesAI & Machine Learning ×1Biotech ×1Cybersecurity ×1Digital Health ×1Hardware ×1IoT ×1Medical Devices ×1
HQs:Italy×1United States×1
Investments · 19 tracked
founders shown can be your intro pathOctave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.
AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US
William Hagstrom(Founder and Chairman)Doug Biehn(President and CEO)
Ermit designs and manufactures connected hardware devices with embedded software and AI capabilities, serving companies building IoT and field-operated products. The company offers end-to-end development from electronics and firmware through data infrastructure and user interfaces, including an integrated IoT security module.
CybersecurityHardwareIoT
Frequently asked questions
- What stage does Hikma Ventures invest at?
- Hikma Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Hikma Ventures's typical check size?
- Hikma Ventures typically writes checks of $5M.
- What sectors does Hikma Ventures focus on?
- Hikma Ventures focuses on Biotech, Digital Health, Medical Devices.
- Does Hikma Ventures lead rounds?
- Yes, Hikma Ventures leads investment rounds.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.